Prevalence of open-angle glaucoma in Iceland: Reykjavik Eye Study. 2003

F Jonasson, and K F Damji, and A Arnarsson, and T Sverrisson, and L Wang, and H Sasaki, and K Sasaki
Department of Ophthalmology University Hospital of Iceland Landspítalinn, Iceland. fridbert@landspirali.is

OBJECTIVE To establish the age- and sex-specific prevalence of open-angle glaucoma (OAG) subsuming pseudoexfoliation (PEX) in the city of Reykjavik. METHODS Participants 50 years of age and older who were part of the Reykjavik Eye Study and classified as having glaucoma were divided into three categories:Category 1: two or more of the following based on optic nerve stereophotograph reading: vertical cup to disc ratio (VCDR) 97.5th percentile (>0.7), focal glaucomatous disc change, C/D asymmetry of 97.5th percentile difference between eyes (>0.2) as well as glaucomatous visual field defect (GVFD). Category 2: 99.5th percentile of VCDR (>0.8) and 99.5% percentile difference between eyes (>/=0.3), without a GVFD. Category 3: VA<3/60 and IOP>99.5th percentile or VA <3/60 and evidence of filtering surgery. For a glaucoma suspect, one of the following was present: VCDR>99.5th percentile (>0.8), focal glaucomatous disc change, C/D asymmetry of 99.5th percentile (> or =0.3), GVFD only, IOP> or =23 mmHg (97.5 percentile). PEX was diagnosed by the presence of a central shield and/or a peripheral band on the anterior lens capsule. RESULTS Of 42 persons (22 males and 20 females) with OAG, 13 (31.0%) had PEX. The minimum prevalence of OAG was 4.0% (42/1045) (95% CI 2.8-5.2) for those 50 years and older and 10.3% (95% CI 8.5-12.2) for PEX. The prevalence of OAG increases with age (OR=1.10/year, 95% CI 1.07-1.13, P=0.000) and the same applies for the prevalence of PEX, OR=1.10 (95% CI 1.07-1.12, P=0.000). CONCLUSIONS There is a 10% annual increase for both OAG and PEX in persons 50 years and older.

UI MeSH Term Description Entries
D007055 Iceland A country in northern Europe, an island between the Greenland Sea and the North Atlantic Ocean, northwest of the United Kingdom. The capital is Reykjavik.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005902 Glaucoma, Open-Angle Glaucoma in which the angle of the anterior chamber is open and the trabecular meshwork does not encroach on the base of the iris. Glaucoma Simplex,Glaucoma, Pigmentary,Glaucoma, Simple,Open-Angle Glaucoma,Chronic Primary Open Angle Glaucoma,Glaucoma, Compensated,Glaucoma, Compensative,Glaucoma, Open Angle,Glaucoma, Primary Open Angle,Glaucoma, Secondary Open Angle,Primary Open Angle Glaucoma,Secondary Open Angle Glaucoma,Compensated Glaucoma,Compensative Glaucoma,Open Angle Glaucoma,Open Angle Glaucomas,Open-Angle Glaucomas,Pigmentary Glaucoma,Simple Glaucoma,Simplex, Glaucoma,Simplices, Glaucoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D014792 Visual Acuity Clarity or sharpness of OCULAR VISION or the ability of the eye to see fine details. Visual acuity depends on the functions of RETINA, neuronal transmission, and the interpretative ability of the brain. Normal visual acuity is expressed as 20/20 indicating that one can see at 20 feet what should normally be seen at that distance. Visual acuity can also be influenced by brightness, color, and contrast. Acuities, Visual,Acuity, Visual,Visual Acuities
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

F Jonasson, and K F Damji, and A Arnarsson, and T Sverrisson, and L Wang, and H Sasaki, and K Sasaki
April 1986, Acta ophthalmologica,
F Jonasson, and K F Damji, and A Arnarsson, and T Sverrisson, and L Wang, and H Sasaki, and K Sasaki
March 2003, Archives of ophthalmology (Chicago, Ill. : 1960),
F Jonasson, and K F Damji, and A Arnarsson, and T Sverrisson, and L Wang, and H Sasaki, and K Sasaki
June 1994, Archives of ophthalmology (Chicago, Ill. : 1960),
F Jonasson, and K F Damji, and A Arnarsson, and T Sverrisson, and L Wang, and H Sasaki, and K Sasaki
October 2007, American journal of ophthalmology,
F Jonasson, and K F Damji, and A Arnarsson, and T Sverrisson, and L Wang, and H Sasaki, and K Sasaki
October 1996, Ophthalmology,
F Jonasson, and K F Damji, and A Arnarsson, and T Sverrisson, and L Wang, and H Sasaki, and K Sasaki
April 2001, Acta ophthalmologica Scandinavica,
F Jonasson, and K F Damji, and A Arnarsson, and T Sverrisson, and L Wang, and H Sasaki, and K Sasaki
February 2014, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban,
F Jonasson, and K F Damji, and A Arnarsson, and T Sverrisson, and L Wang, and H Sasaki, and K Sasaki
January 1992, European journal of ophthalmology,
F Jonasson, and K F Damji, and A Arnarsson, and T Sverrisson, and L Wang, and H Sasaki, and K Sasaki
October 2011, Investigative ophthalmology & visual science,
F Jonasson, and K F Damji, and A Arnarsson, and T Sverrisson, and L Wang, and H Sasaki, and K Sasaki
December 1980, Archives of ophthalmology (Chicago, Ill. : 1960),
Copied contents to your clipboard!